NexPoint Life Sciences III DST

Amendment

CIK: 0002008210·Other Real Estate·DELAWARE·Filed: Aug 11, 2026

Total Offering

$30,661,253

Amount Sold

$27,965,695

Investors

92

First Sale

Jan 25, 2024

Offering Details

Type: Equity, Pooled Investment Fund
Exemptions: Rule 506(c), Section 3(c), Section 3(c)(1), Section 3(c)(5)
Entity Type: Other
Year Incorporated: 2023
Non-Accredited Investors: No

Related Persons

Name	Role
N/A NexPoint Real Estate Advisors IV, L.P.
Brian Mitts
Matt McGraner
N/A NREA LS III Manager, LLC
N/A NREA LS III Contributor, LLC

Company

NexPoint Life Sciences III DST

300 CRESCENT COURT

DALLAS, TX, 75201

(833) 697-6246

SEC Filing

0002008210-26-000003

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.